Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tigris: Bimatoprost Implant with SpyGlass IOL in Glaucoma/OHT
NCT06120842Phase 2Active, not recruiting
- Start
- Oct 2023
- Primary completion
- Jan 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of bimatoprost in open-angle glaucoma (OAG), ocular hypertension. Started Oct 2023; status: active, not recruiting.
02
Drugs
bimatoprost
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT06120842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06120842.